H

Hologic

HOLX

83.220
USD
1.61
(1.97%)
Market Open
Volume
21,546
EPS
0
Div Yield
0
P/E
28
Market Cap
18,937,128,496
Related Instruments
A
1.430
(1.01%)
142.860 USD
ABT
4.220
(3.98%)
110.150 USD
B
BAX
0.190
(0.53%)
36.000 USD
BDX
-4.995
(-2.07%)
236.055 USD
BSX
1.315
(1.78%)
75.170 USD
C
COO
0.880
(0.94%)
94.200 USD
D
DGX
5.430
(3.81%)
147.770 USD
H
HOLX
1.610
(1.97%)
83.220 USD
I
IDXX
1.95
(0.41%)
477.81 USD
ISRG
6.98
(1.57%)
451.27 USD
MDT
0.160
(0.20%)
80.470 USD
P
PKI
1.920
(1.57%)
124.190 USD
SYK
5.59
(1.71%)
332.94 USD
TMO
9.03
(1.47%)
621.78 USD
News

Title: Hologic

Sector: Healthcare
Industry: Medical Instruments & Supplies
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.